These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34195098)

  • 1. Corrigendum: Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review.
    Rony M; Ratone JP; Walz J; Pignot G; Caillol F; Pesenti C; Guerin M; Dermeche S; Brunelle S; Salem N; Vicier C; Rybikowski S; Maubon T; Fakhfakh S; Tejeda M; Giovannini M; Gravis G
    Front Oncol; 2021; 11():710477. PubMed ID: 34195098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review.
    Maelle R; Jean-Philippe R; Jochen W; Geraldine P; Fabrice C; Christian P; Mathilde G; Slimane D; Serge B; Naji S; Cecile V; Stanislas R; Thomas M; Sami F; Manuel T; Marc G; Gwenaelle G
    Front Oncol; 2021; 11():644301. PubMed ID: 33833995
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum: Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.
    Arezzo F; Giannone G; Castaldo D; Scotto G; Tuninetti V; Turinetto M; Bartoletti M; Mammoliti S; Artioli G; Mangili G; Salutari V; Lorusso D; Cormio G; Loizzi V; Zamagni C; Savarese A; Di Maio M; Ronzino G; Pisano C; Pignata S; Valabrega G
    Front Oncol; 2023; 13():1357793. PubMed ID: 38318323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors.
    Hou T; Jiang S; Wang Y; Xie Y; Zhang H; Feng Y; Ma F; Ma J; Liu X; Hu C
    Front Oncol; 2021; 11():705406. PubMed ID: 34150669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum:
    Xu S; Hu C; Jiang Z; Li G; Zhou B; Gao Z; Wang W; Yan S
    Front Oncol; 2023; 13():1251636. PubMed ID: 37637040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: a case report and review of the literature.
    Lolli J; Tessari F; Berti F; Fusella M; Fiorentin D; Bimbatti D; Basso U; Busato F
    Front Oncol; 2023; 13():1278074. PubMed ID: 37790753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Brain Metastases From Lung Adenocarcinoma May Preferentially Involve the Distal Middle Cerebral Artery Territory and Cerebellum.
    Kwon H; Kim JW; Park M; Kim JW; Kim M; Suh SH; Chang YS; Ahn SJ; Lee JM
    Front Oncol; 2020; 10():610495. PubMed ID: 33240821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.
    Chen Q; Ouyang D; Anwar M; Xie N; Wang S; Fan P; Qian L; Chen G; Zhou E; Guo L; Gu X; Ding B; Yang X; Liu L; Deng C; Xiao Z; Li J; Wang Y; Zeng S; Hu J; Zhou W; Qiu B; Wang Z; Weng J; Liu M; Li Y; Tang T; Wang J; Zhang H; Dai B; Tang W; Wu T; Xiao M; Li X; Liu H; Li L; Yi W; Ouyang Q
    Front Oncol; 2021; 11():661128. PubMed ID: 33747972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Flavonoid Derivative of
    Moreau M; Ibeh U; Decosmo K; Bih N; Yasmin-Karim S; Toyang N; Lowe H; Ngwa W
    Front Oncol; 2020; 10():1434. PubMed ID: 32974159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis Patients.
    Chen H; Dai S; Fang Y; Chen L; Jiang K; Wei Q; Ding K
    Front Oncol; 2021; 11():742987. PubMed ID: 34490128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience.
    Lin LC; Huang WK; Yen CC; Yang CY; Sung MT; Wong NSM; Chua DTT; Lee SWM; Chen JS; Yeh CN
    Front Oncol; 2022; 12():1028118. PubMed ID: 36313668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells.
    Huang SS; Liao WY; Hsu CC; Chan TS; Liao TY; Yang PM; Chen LT; Sung SY; Tsai KK
    Front Oncol; 2021; 11():718849. PubMed ID: 34239806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Isothermal Microcalorimetry of Tumor Cells: Enhanced Thermogenesis by Metastatic Cells.
    Lemos D; Oliveira T; Martins L; de Azevedo VR; Rodrigues MF; Ketzer LA; Rumjanek FD
    Front Oncol; 2020; 10():367. PubMed ID: 32266147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients.
    Rong X; Lv J; Liu Y; Wang Z; Zeng D; Li Y; Li S; Wu J; Shen Z; Shi M; Liao W; Wu Z; Wang C
    Front Oncol; 2022; 12():895938. PubMed ID: 35463347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer.
    Zheng Y; Zhong G; Yu K; Lei K; Yang Q
    Front Oncol; 2020; 10():482. PubMed ID: 32328463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Pyruvate kinase M2 promotes prostate cancer metastasis through regulating ERK1/2-COX-2 signaling.
    Guo W; Zhang Z; Li G; Lai X; Gu R; Xu W; Chen H; Xing Z; Chen L; Qian J; Xu S; Zeng F; Deng F
    Front Oncol; 2024; 14():1323020. PubMed ID: 38410110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Comparison of prognosis between microscopically positive and negative surgical margins for primary gastrointestinal stromal tumors: A systematic review and meta-analysis.
    Liu Z; Zhang Y; Yin H; Geng X; Li S; Zhao J; Zeng Z; Ye X; Yu J; Feng F; Kang W
    Front Oncol; 2022; 12():1110168. PubMed ID: 36761432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies.
    Cao J; Zhang M; Wang B; Zhang L; Zhou F; Fang M
    Front Oncol; 2021; 11():745052. PubMed ID: 34485165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.
    Ghatalia P; Smith CH; Winer A; Gou J; Kiedrowski LA; Slifker M; Saltzberg PD; Bubes N; Anari FM; Kasireddy V; Varshavsky A; Liu Y; Ross EA; El-Deiry WS
    Front Oncol; 2021; 11():674782. PubMed ID: 34026652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis.
    Zhang W; Wang W; Wu J; Tian J; Yan W; Yuan Y; Yao Y; Shang A; Quan W
    Front Oncol; 2022; 12():1118042. PubMed ID: 36591456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.